Control of glutamatergic neurotransmission in the rat spinal dorsal horn by the nucleoside transporter ENT1

Journal of Physiology

Volumn 548, Issue 2, 2003, Pages 507-517

  Ackley, Michael A ^a   Governo, Ricardo J M ^a   Cass, Carol E ^b   Young, James D ^b   Baldwin, Stephen A ^a   King, Anne E ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE DEAMINASE; CARRIER PROTEIN; ENT1 PROTEIN; GLUTAMIC ACID; NITROBENZYLTHIOINOSINE; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; NUCLEOSIDE TRANSPORTER; NUCLEOSIDE TRANSPORTER ENT1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGRADATION KINETICS; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MEMBRANE TRANSPORT; MODULATION; NERVE CELL; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; NUCLEOSIDE TRANSPORT; PATCH CLAMP; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SPINAL CORD; SPINAL CORD DORSAL HORN; SUBSTANTIA GELATINOSA; SYNAPTIC TRANSMISSION; TISSUE HOMOGENATE; TISSUE SLICE; ADULT; CONCENTRATION (PARAMETERS); EVOKED RESPONSE; GLUTAMATERGIC SYNAPSE; PRESYNAPTIC MEMBRANE; PROTEIN FUNCTION; PROTEIN LOCALIZATION; WHOLE CELL PATCH CLAMP;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EXCITATORY POSTSYNAPTIC POTENTIALS; FEMALE; GLUTAMIC ACID; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MEMBRANE POTENTIALS; NUCLEOSIDE TRANSPORT PROTEINS; PATCH-CLAMP TECHNIQUES; POSTERIOR HORN CELLS; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A1; RECOMBINANT PROTEINS; SYNAPSES; SYNAPTIC TRANSMISSION; THIOINOSINE; XANTHINES;

EID: 0038069054     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2002.038091     Document Type: Article

References (47)

1. Anderson CM, Baldwin SA, Young JD, Cass CE & Parkinson FE (1999a). Distribution of mRNA encoding a nitrobenzylthioinosine-insensitive nucleoside transporter (ENT2) in rat brain. Brain Res Mol Brain Res 70, 293-297.
2. Anderson CM, Xiong W, Geiger JD, Young JD, Cass CE, Baldwin SA & Parkinson FE (1999b). Distribution of equilibrative, nitrobenzylthioinosine-sensitive nucleoside transporters (ENT1) in brain. J Neurochem 73, 867-873.
3. Bagley EE, Vaughan CW & Christie MJ (1999). Inhibition by adenosine receptor agonists of synaptic transmission in rat periaqueductal grey neurons. J Physiol 516, 219-225.
4. Bird GC, Asghar AUR, Ackley MA & King AE (2001). Modulation of primary afferent-mediated neurotransmission and Fos expression by glutamate uptake inhibition in rat spinal neurones in vitro. Neuropharmacology 41, 582-591.
5. Bleazard L, Hill RG & Morris R (1994). The correlation between the distribution of the NK1 receptor and the actions of tachykinin agonists in the dorsal horn of the rat indicates that substance P does not have a functional role on substantia gelatinosa (lamina II) neurons. J Neurosci 14, 7655-7664.
6. Boyle DL, Kowaluk EA, Jarvis MF, Lee CH, Bhagwat SS, Williams M & Firestein GS (2001). Anti-inflammatory effects of ABT-702, a novel non-nucleoside adenosine kinase inhibitor, in rat adjuvant arthritis. J Pharmacol Exp Ther 296, 495-500.
7. Cassar M, Jones MG & Szatkowski M (1998). Reduced adenosine uptake accelerates ischaemic block of population spikes in hippocampal slices from streptozotocin-treated diabetic rats. Eur J Neurosci 10, 239-245.
8. Cuhna RA (2001). Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem Int 38, 107-125.
9. Deuchars SA, Brooke RE & Deuchars J (2001). Adenosine A1 receptors reduce release from excitatory but not inhibitory synaptic inputs onto lateral horn neurons. J Neurosci 21, 6308-6320.
10. Dunwiddie TV (1985). The physiological role of adenosine in the central nervous system. Int Rev Neurobiol 27, 63-139.
11. Fowler JC (1989). Adenosine antagonists delay hypoxia-induced depression of neuronal activity in hippocampal brain slice. Brain Res 490, 378-384.
12. 3H] nitrobenzylthioinosine binding in developing rat brain. Brain Res 436, 265-272.
13. Geiger JD, Labella FS & Nagy JI (1984). Ontogenesis of adenosine receptors in the central nervous system of the rat. Dev Brain Res 13, 97-104.
14. Geiger JD, Labella FS & Nagy JI (1985). Characterization of nitrobenzylthioinosine binding to nucleoside transport sites selective for adenosine in rat brain. J Neurosci 5, 735-740.
15. 3H] nitrobenzylthioinosine binding sites in rat spinal cord and primary afferent neurons. Brain Res 347, 321-327.
16. Griffith DA & Jarvis SM (1996). Nucleoside and nucleobase transport systems of mammalian cells. Biochem Biophys Acta 1286, 153-181.
17. Griffiths M, Beaumont N, Yao SY, Sundaram M, Boumah CE, Davies A, Kwong FY, Coe I, Cass CE, Young JD & Baldwin SA (1997a). Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nat Med 3, 89-93.
18. Griffiths M, Yao SY, Abidi F, Phillips SE, Cass CE, Young JD & Baldwin SA (1997b). Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta. Biochem J 328, 739-743.
19. Haas HL & Selbach O (2000). Functions of neuronal adenosine receptors. Naunyn-Schmiedebergs Arch Pharmacol 362, 375-381.
20. Honore P, Buritova J, Chapman V & Besson JM (1998). UP 202-56, an adenosine analogue, selectively acts via A1 receptors to significantly decrease noxiously-evoked spinal c-Fos protein expression. Pain 75, 281-293.
21. Hyde RJ, Cass CE, Young JD & Baldwin SA (2001). The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms. Mol Membr Biol 18, 53-63.
22. Jarvis MF, Yu H, Kohlhaas K, Alexander K, Lee CH, Jiang M, Bhagwat SS, Williams M & Kowaluk EA (2000). ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse. J Pharmacol Exp Ther 295, 1156-1164.
23. Jennings LL, Hao C, Cabrita MA, Vickers MF, Baldwin SA, Young JD & Cass CE (2001). Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system. Neuropharmacology 40, 722-731.
24. Johansson B, Halldner L, Dunwiddie TV, Masino SA, Poelchen W, Gimenez-Llort L, Escorihuela RM, Fernandez-Teruel A, Wiesenfeld-Hallin Z, Xu XJ, Hardemark A, Betsholtz C, Herlenius E & Fredholm BB (2001). Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc Natl Acad Sci U S A 98, 9407-9412.
25. Keil GJ & Delander GE (1992). Spinally-mediated antinociception is induced in mice by an adenosine kinase-, but not by an adenosine deaminase-, inhibitor. Life Sci 51, 171-176.
26. Keil GJ & Delander GE (1995). Time-dependent antinociceptive interactions between opioids and nucleoside transport inhibitors. J Pharmacol Exp Ther 274, 1387-1392.
27. Kim J & Alger BE (2001). Random response fluctuations lead to spurious paired-pulse facilitation. J Neurosci 21, 9608-9618.
28. Kowaluk EA, Kohlhaas KL, Bannon A, Gunther K, Lynch JJ & Jarvis MF (1999). Characterization of the effects of adenosine kinase inhibitors on acute thermal nociception in mice. Pharmacol Biochem Behav 63, 83-91.
29. Kowaluk EA, Mikusa J, Wismer CT, Zhu CZ, Schweitzer E, Lynch JJ, Lee CH, Jiang M, Bhagwat SS, Gomtsyan A, McKie J, Cox BF, Polakowski J, Reinhart G, Williams M & Jarvis MF (2000). ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl) pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat. J Pharmacol Exp Ther 295, 1165-1174.
30. Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
31. Lao LJ, Kumamoto E, Luo C, Furue H & Yoshimura M (2001). Adenosine inhibits excitatory transmission to substantia gelatinosa neurons of the adult rat spinal cord through the activation of presynaptic A(1) adenosine receptor. Pain 94, 315-324.
32. Lee CW & Jarvis SM (1988). Nucleoside transport in rat cerebral-cortical synaptosomes. Evidence for two types of nucleoside transporters. Biochem J 249, 557-564.
33. Lupica CR, Proctor WR & Dunwiddie TV (1992). Presynaptic inhibition of excitatory synaptic transmission by adenosine in rat hippocampus: analysis of unitary EPSP variance measured by whole-cell recording. J Neurosci 12, 3753-3764.
34. Musa H, Dobrzynski H, Berry Z, Abidi F, Cass JD, Young SA, Baldwin SA & Boyett MR (2002). Immunocytochemical demonstration of the equilibrative nucleoside transporter rENT1 in rat sinoatrial node. J Histochem Cytochem 50, 305-309.
35. Patel MK, Pinnock RD & Lee K (2001). Adenosine exerts multiple effects in dorsal horn neurones of the adult rat spinal cord. Brain Res 920, 19-26.
36. Poon A & Sawynok J (1998). Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat. Pain 74, 235-245.
37. Reeve AJ & Dickenson AH (1995). The roles of spinal adenosine receptors in the control of acute and more persistent nociceptive responses of dorsal horn neurones in the anaesthetized rat. Br J Pharmacol 116, 2221-2228.
38. Rudolphi KA, Schubert P, Parkinson FE & Fredholm BB (1992). Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol Sci 13, 439-445.
39. Sanderson G & Scholfield CN (1986). Effects of adenosine uptake blockers and adenosine on evoked potentials of guinea-pig olfactory cortex. Pflügers Arch 406, 25-30.
40. Sawynok J (1998). Adenosine receptor activation and nociception. Eur J Pharmacol 347, 1-11.
41. Sawynok J, Sweeney MI & White TD (1986). Classification of adenosine receptors mediating antinociception in the rat spinal cord. Br J Pharmacol 88, 923-930.
42. Scanziani M, Salin PA, Vogt KE, Malenka RC & Nicoll RA (1997). Use-dependent increases in glutamate concentration activate presynaptic metabotropic glutamate receptors. Nature 385, 630-634.
43. Smith JA, Sivaprasadarao A, Munsey TS, Bowmer CJ & Yates MS (2001). Immunolocalisation of adenosine A(1) receptors in the rat kidney. Biochem Pharmacol 61, 237-244.
44. Sundaram M, Yao SY, Ingram JC, Berry ZA, Abidi F, Cass CE, Baldwin SA & Young JD (2001). Topology of a human equilibrative, nitrobenzylthioinosine (NBMPR)-sensitive nucleoside transporter (hENT1) implicated in the cellular uptake of adenosine and anti-cancer drugs. J Biol Chem 276, 45270-45275.
45. Wu J-SR, Kwong FYP, Jarvis SM & Young JD (1983). Identification of the erythrocyte nucleoside transporter as a band 4.5 polypeptide. J Biol Chem 258, 13745-13751.
46. Yao SY, Ng AM, Muzyka WR, Griffiths M, Cass CE, Baldwin SA & Young JD (1997). Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues. J Biol Chem 272, 28423-28430.
47. Yoshimura M & Nishi S (1993). Blind patch-clamp recordings from substantia gelatinosa neurons in adult rat spinal cord slices: pharmacological properties of synaptic currents. Neurosci 53, 519-526.